- This event has passed.
FEBS 2024 Advanced Course | Transglutaminases in human disease processes
May 19 to May 23
Dear colleagues and friends,
The FEBS Workshop is a much anticipated scientific meeting on known and emerging transglutaminase-related diseases, new methods for detection and novel translational aspects for treatment. It aims to bring together an international group of senior academic and industrial members, with as many as possible early career scientists, future leaders and drivers of this expanding field. The Workshop will feature presentations relevant to all the pathological conditions for which transglutaminase is a relevant target, and will also focus on emerging diseases associated with this class of enzymes, and new methods for their investigation. Additional training sessions will focus on career development and grant capturing. There will be plenty of opportunities for poster or selected oral presentations. Our evening programme is designed to encourage networking and to enjoy all that idyllic Bertinoro has to offer.
Elisabetta Verderio Edwards, Chair
Kiyotaka Hitomi, Co-Chair
IUBMB LECTURER: Professor Jeffrey W. Keillor, PhD, FCIC, University of Ottawa, ON, Canada
Jeffrey W. Keillor began his academic career in 1995 in the Chemistry Department at the Université de Montréal. In 2011 he moved to the Department of Chemistry and Biomolecular Sciences of the University of Ottawa, where he held a University Research Chair in Bioorganic Chemistry until 2021. His research program is situated at the interface of chemistry and biochemistry, in the fields of chemical biology and medicinal chemistry. In 2017 he won the Bernard Belleau Award for his work in the field of medicinal chemistry, and in 2020 he was named a Fellow of the Chemical Institute of Canada (FCIC).
FEB 11: Travel grant applications EXTENDED deadline (young scientists)
MAR 22: Regular early-bird registrations deadline (young and senior scientists)
MAY 03: Regular “late” registrations deadline
AUG 31: Recommended date for hotel reservation
APR 12: Abstract final deadline